A phase 2, open‐label study of single dose dupilumab in children aged 6 months to < 6 years with severe uncontrolled atopic dermatitis: Pharmacokinetics, safety and efficacy
Journal of the European Academy of Dermatology and Venereology | Sep 11, 2020
Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: A randomized controlled trial
Journal of the American Academy of Dermatology | Sep 06, 2020
Incidence and risk factors for dupilumab associated ocular adverse events: A real‐life prospective study
Journal of the European Academy of Dermatology and Venereology | Jul 31, 2020
Most read this week